Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Study Identifies How Tamoxifen Stimulates Uterine Cell Growth And Cancer
UCSF researchers have identified a new "feed-forward" pathway linking estrogen receptors in the membrane of the uterus to a process that increases local estrogen levels and promotes cell growth.
generic viagra online
Efforts To Quickly Develop Swine Flu Vaccine Reported In GEN
Scientists around the world are accelerating their efforts to develop a vaccine against the H1N1 influenza virus (Swine flu) as rapidly as possible, reports Genetic Engineering & Biotechnology News (GEN). The need for such a vaccine received a strong impetus from the World Health Organization, which has issued a Phase 5 pandemic alert, a strong signal that the WHO believes a pandemic is imminent, according to the June 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2938).
News of the day
Individuals At Risk For Developing Colon Cancer Identified By Researchers
A new study identifies a group of individuals at increased risk for developing colon cancer and holds the promise for developing new tailored cancer treatments. The study in this week"s issue of the Proceedings of the National Academy of Sciences (PNAS) is by Sanford Markowitz, M.D., Ph.D., the Markowitz-Ingalls Professor of Cancer Genetics at Case Western Reserve University School of Medicine and oncologist at the Ireland Cancer Center of University Hospitals Case Medical Center, and colleagues.
Sexual Health

22nd Congress Of The European College Of Neuropsychopharmacology

The 22nd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 12-16 September 2009 in Istanbul, Turkey. More than 6,500 clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world will attend the ECNP Congress, which is the largest annual high scientific standard congress on mental disorders and neuropsychopharmacology in Europe. Renowned experts from 25 countries will present the latest achievements and breakthroughs in neuropsychopharmacology and related disciplines in both clinical and preclinical settings, as well as discuss the various aspects of pharmacotherapy of brain disorders and their impact on patients÷´ quality of life. The scientific programme will comprise, among others, the following topics: * The future of schizophrenia * The role of genetic factors in adult ADHD * Is the monoamines involved in shaping conduct disorder? * Vaccination for Alzheimer÷´s disease in dementia * Novel treatment for smoking * Maternal serotonin * Deep Brain Stimulation: new perspectives for treatment * News on the NewMood project Furthermore, the educational update sessions at the congress will deal with the current knowledge on GABA and biomarkers in neuropsychopharmacology, treatment of insomnia, bipolar disorders and schizophrenia, and the new classification systems ICD-11 and DSM-V. For further information about the provisional scientific programme, please visit the ECNP website: http://www.ecnp.eu Sonja Mak European College of Neuropsychopharmacology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009